Skip to main content

Profund Advisors LLC

SEC CIK
0001129919
Latest filing
Aug 11, 2026

DNLI holding history

Denali Therapeutics Inc. in every 13F filed by Profund Advisors LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

DNLI overviewAll 13F holders of DNLIFull Q2 2026 holdings

Shares (Q2 2026)
49,899
Value
$1.28M
% of portfolio
<0.1%
Quarters held
21
Since Q2 2021
Holdings of DNLI by Profund Advisors LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202649,899$1.28M<0.1%−18,328−26.9%ReducedHolders
Q1 202668,227$1.31M<0.1%−3,407−4.8%ReducedHolders
Q4 202571,634$1.18M<0.1%+31,478+78.4%AddedHolders
Q3 202540,156$583.1K<0.1%+13,433+50.3%AddedHolders
Q2 202526,723$373.9K<0.1%−1,146−4.1%ReducedHolders
Q1 202527,869$378.9K<0.1%−866−3.0%ReducedHolders
Q4 202428,735$585.6K<0.1%+3,877+15.6%AddedHolders
Q3 202424,858$724.1K<0.1%−4,515−15.4%ReducedHolders
Q2 202429,373$682.0K<0.1%−39,101−57.1%ReducedHolders
Q1 202468,474$1.41M0.1%+14,799+27.6%AddedHolders
Q4 202353,675$1.15M<0.1%+13,521+33.7%AddedHolders
Q3 202340,154$828.4K<0.1%−6,321−13.6%ReducedHolders
Q2 202346,475$1.37M0.1%−2,352−4.8%ReducedHolders
Q1 202348,827$1.12M0.1%+33,960+228.4%AddedHolders
Q4 202214,867$413.5K<0.1%+1,905+14.7%AddedHolders
Q3 202212,962$398.0K<0.1%+186+1.5%AddedHolders
Q2 202212,776$376.0K<0.1%−1,478−10.4%ReducedHolders
Q1 202214,254$459.0K<0.1%−1,586−10.0%ReducedHolders
Q4 202115,840$706.0K<0.1%−1,813−10.3%ReducedHolders
Q3 202117,653$891.0K<0.1%+14,982+560.9%AddedHolders
Q2 20212,671$210.0K<0.1%+2,671NewHolders